Have a personal or library account? Click to login
Stability studies of chitosan-DNA-FAP-B nanoparticles for gene delivery to lung epithelial cells Cover

Stability studies of chitosan-DNA-FAP-B nanoparticles for gene delivery to lung epithelial cells

Open Access
|Apr 2012

References

  1. S. Mansouria, Y. Cuieb, F. Winnikb, Q. Shia, P. Lavignea, M. Benderdoura, E. Beaumonta and J. C. Fernandes, Characterization of folate-chitosan-DNA nanoparticles for gene therapy, Biomaterials 27 (2006) 2060-2065; DOI: 10.1016/j.biomaterials.2005.09.020.10.1016/j.biomaterials.2005.09.020
  2. Z. Cui and R. J. Mumper, Chitosan-based nanoparticles for topical genetic immunization, J. Control. Release 75 (2001) 409-419; DOI: 10.1016/s0168-3659(01)00407-2.10.1016/S0168-3659(01)00407-2
  3. F. C. MacLaughlin, R. J. Mumper, J. Wang, J. M. Tagliaferri, I. Gill, M. Hinchcliffe and A. P. Rolland, Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery, J. Control. Release 56 (1998) 259-272; DOI: 10.1016/s0168-3659(98)00097-2.10.1016/S0168-3659(98)00097-2
  4. S. Safari, F. A. Dorkoosh, M. Soleimani, M. H. Zarrintan, H. Akbari, B. Larijani and M. Rafiee Tehrani, N-Diethylmethyl chitosan for gene delivery to pancreatic cancer cells and the relation between charge ratio and biologic properties of polyplexes via interpolations polynomial, Int. J. Pharm. 420 (2011) 350-357; DOI: 10.1016/j.ijpharm.2011.08.050.10.1016/j.ijpharm.2011.08.050
  5. M. Abolhassani, M. Lagranderie, I. Caminshi, F. Romain, A. Balazuc, M. Wagner, M. Tanguy, L. Fiette, I. Sobhani, G. Milon and G. Marchal, Similar functional activity of dendritic cells recruited to the mesenteric lymph nodes of newborn and adult mice after the rectal delivery of Mycobacterium bovis BCG, Microbes Infect 8 (2006) 2341-2351; DOI: 10.1016/j.micinf.2006.03.022.10.1016/j.micinf.2006.03.022
  6. Z. Mohammadi, M. Abolhassani, F. A. Dorkoosh, S. Hosseinkhani, K. Gilani, T. Amini, A. Rouholamini Najafabadi and M. Rafiee Tehrani, Preparation and evaluation of chitosan-DNA-FAP-B nanoparticles as a novel non-viral vector for gene delivery to the lung epithelial cells, Int. J. Pharm. 409 (2011) 307-313; DOI:10.1016/j.ijpharm.2011.02.043.10.1016/j.ijpharm.2011.02.043
  7. Z. Mohammadi, F. A. Dorkoosh, S. Hosseinkhani, K. Gilani, T. Amini, A. Rouholamini Najafabadi and M. Rafiee Tehrani, In vivo transfection study of chitosan-DNA-FAP-B nanoparticles as a new non viral vector for gene delivery to the lung, Int. J. Pharm. 421 (2011) 183-188; DOI: 10.1016/j.ijpharm.2011.09.029.10.1016/j.ijpharm.2011.09.029
  8. M. S. Muthu and S. Feng, Pharmaceutical stability aspects of nanomedicines, Nanomedicine 4 (2009) 857-860; DOI:10.2217/nnm.09.75.10.2217/nnm.09.75
  9. International Conference on Harmonization, ICH Q1A (R2), Stability Testing Guidelines: Stability Testing of New Drug Substances and Products, ICH step 5, CPMP/ICH/2736/99, London 2003.
  10. F. Romain, A. Laqueyrerie, P. Militzer, P. Pescher, P. Chavarot, M. La-Granderie, G. Auregan, M. Gheorghiu and G. Marchal, Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria, Infect. Immun 61 (1993) 742-750.10.1128/iai.61.2.742-750.1993
  11. M. Elfinger, J. Geiger, G. Hasenpusch, S. Üzgün, N. Sieverling, M. K. Aneja, C. Maucksch and C. Rudolph, Targeting of the β2-adrenoceptor increases nonviral gene delivery to pulmonary epithelial cells in vitro and lungs in vivo, J. Control. Release 135 (2009) 234-241; DOI: 10.1016/j.jcourel.2009.01.012.
  12. H. Mao, K. Roy, V. Troung-Le, K. A. Janes, K. Y. Lin, Y. Wang, J. T. August and K. W. Leong, Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency, J. Control. Release 70 (2001) 399-421; DOI: 10.1016/s0168-3659(00)00361-8.10.1016/S0168-3659(00)00361-8
  13. International Conference on Harmonization, ICH Q5C, Stability Testing of Biotechnological/Biological Products, ICH step 4, CPMP/ICH/138/95, London 1996.
  14. T. Arakawa, S. J. Prestrelski, W. C. Kenney and J. F. Carpenter, Factors affecting short-term and long-term stabilities of proteins, Adv. Drug Deliver. Rev. 46 (2001) 307-326; DOI: 10.1016/s0169-409x(00)00144-7.10.1016/S0169-409X(00)00144-7
  15. G. Borchard, Chitosans for gene delivery, Adv. Drug Deliver. Rev. 52 (2001) 145-150; DOI: 10.1016/s0169-409x(01)00198-3.10.1016/S0169-409X(01)00198-3
  16. H. Okamoto, Y. Sakakura, K. Shiraki, K. Oka, S. Nishida, H. Todo, K. Iida and K. Danjo, Stability of chitosan-pDNA complex powder prepared by supercritical carbon dioxide process, Int. J. Pharm 290 (2005) 73-81; DOI: 10.1016/j.ijpharm.2004.11.026.10.1016/j.ijpharm.2004.11.026
  17. W. Walther, U. Stein, C. Voss, T. Schmidt, M. Schleef and P. M. Schlag, Stability analysis for long-term storage of naked DNA: impact on nonviral in vivo gene transfer, Anal. Biochem 318 (2003) 230-235; DOI: 10.1016/s0003-2697(03)00244-6.10.1016/S0003-2697(03)00244-6
  18. D. M. Prazeres, G. N. M. Ferreira, G. A. Monteiro, C. L. Cooney and J. M. S. Cabral, Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: problems and bottlenecks, Trends Biotechnol. 17 (1999) 169-174; DOI: 10.1016/s0167-7799(98)01291-8.10.1016/S0167-7799(98)01291-8
DOI: https://doi.org/10.2478/v10007-012-0008-z | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 83 - 92
Published on: Apr 3, 2012
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2012 Zohreh Mohammadi, Farid Dorkoosh, Saman Hosseinkhani, Tina Amini, Amir Rahimi, Abdolhossein Najafabadi, Morteza Tehrani, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 62 (2012): Issue 1 (March 2012)